Journal of The Korean Dental Society of Anesthesiology (대한치과마취과학회지)

The Korean Dental Society of Anesthsiology (대한치과마취과학회)
권호 표지

Comparison of Efficacy of Propofol When Used with or without Remifentanil during Conscious Sedation with a Target-Controlled Infuser for Impacted Teeth Extraction

  • Sung, Juhan (School of Dentistry, Seoul National University) ;
  • Kim, Hyun-Jeong (Department of Dental Anesthesiology, School of Dentistry, Seoul National University) ;
  • Choi, Yoon Ji (Department of Dental Anesthesiology, Seoul National University Dental Hospital) ;
  • Lee, Soo Eon (Department of Dental Anesthesiology, Seoul National University Dental Hospital) ;
  • Seo, Kwang-Suk (Department of Dental Anesthesiology, School of Dentistry, Seoul National University)
  • Received : 2014.12.30
  • Accepted : 2015.01.05
  • Published : 2014.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Clinical use of propofol along with remifentanil for intravenous sedation is increasing in these days, but there are not enough researches to evaluate proper target concentration when these drugs are infused by using target controlled infusion (TCI) pump in dental treatment cases. In this study, we compared efficacy of TCI conscious sedation and target concentration of propofol when it used with or without remifentanil during conscious sedation with the help of a TCI for the surgical extraction of impacted teeth. Methods: After IRB approval, all the charts of patients who had undergone surgical extraction of impacted teeth under propofol TCI sedation for 6 months were selected and reviewed for this study. After reviewal of charts, we could divide patients in two groups. In one group (group 1), only propofol was selected for sedation and initial effect site concentration of propofol was $1{\mu}g/ml$ (n = 33), and in another group (group 2), both propofol and remifentanil was infused and initial effect site concentration of each drug was $0.6{\mu}g/ml$ and 1 ng/ml respectively (n = 25). For each group, average propofol target concentration was measured. In addition, we compared heart rate, respiratory rate, and systolic and diastolic blood pressure as well as oxygen saturation. Besides, BIS, sedation scores (OAAS/S), and subjective satisfaction scores were compared. Results: Between group 1 and 2, there were no significant differences in demographics (age, weight and height), and total sedation time. However, total infused dose and the effect site target concentration of propofol was $163.8{\pm}74.5mg$ and $1.13{\pm}0.21{\mu}g/ml$ in group 1, and $104.3{\pm}46.5mg$ and $0.72{\pm}0.26{\mu}g/ml$ in the group 2 with $1.02{\pm}0.21ng/l$ of the effect site target concentration of remifentanil, respectively. During sedation, there were no differences between overall vital sign, BIS and OAAS/S in 2 groups (P > 0.05). However, we figured out patients in group 2 had decreased pain sensation during sedation. Conclusions: Co-administration of propofol along with remifentanil via a TCI for the surgical extraction of impacted teeth may be safe and effective compared to propofol only administration.

Keywords

References

  1. Leitch J and Macpherson A. Current state of sedation/ analgesia care in dentistry. Curr Opin Anaesthesiol 2007; 20(4): 384-7. https://doi.org/10.1097/ACO.0b013e32825ea2a4
  2. Guarracino F, Penzo D, De Cosmo D, Vardanega A and De Stefani R. Pharmacokinetic-based total intravenous anaesthesia using remifentanil and propofol for surgical myocardial revascularization. Eur J Anaesthesiol 2003; 20(5): 385-90. https://doi.org/10.1097/00003643-200305000-00006
  3. Suttner S, Boldt J, Schmidt C, Piper S and Kumle B. Cost analysis of target-controlled infusion-based anesthesia compared with standard anesthesia regimens. Anesth Analg 1999; 88(1): 77-82.
  4. Theilen HJ, Adam S, Albrecht MD and Ragaller M. Propofol in a medium- and long-chain triglyceride emulsion: pharmacological characteristics and potential beneficial effects. Anesth Analg 2002; 95(4): 923-9, table of contents.
  5. Mckeage K and Perry CM. Propofol: a review of its use in intensive care sedation of adults. CNS Drugs 2003; 17(4): 235-72. https://doi.org/10.2165/00023210-200317040-00003
  6. Scott LJ and Perry CM. Remifentanil: a review of its use during the induction and maintenance of general anaesthesia. Drugs 2005; 65(13): 1793-823. https://doi.org/10.2165/00003495-200565130-00007
  7. Rewari V, Madan R, Kaul HL and Kumar L. Remifentanil and propofol sedation for retrobulbar nerve block. Anaesth Intensive Care 2002; 30(4): 433-7.
  8. Guarracino F, Lapolla F, Cariello C, Danella A, Doroni L, Baldassarri R, et al. Target controlled infusion: TCI. Minerva Anestesiol 2005; 71(6): 335-7.
  9. Collini S, Pinto G, Lejeune L, Di Carlo S, Meloncelli S, Barraco G, et al. Neurosedation in dentistry of the disabled patient: the use of midazolam, propofol, and remifentanil. Minerva Stomatol 2006; 55(3): 99-113.
  10. Lacombe GF, Leake JL, Clokie CM and Haas DA. Comparison of remifentanil with fentanyl for deep sedation in oral surgery. J Oral Maxillofac Surg 2006; 64(2): 215-22. https://doi.org/10.1016/j.joms.2005.10.026
  11. Rai MR, Parry TM, Dombrovskis A and Warner OJ. Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. Br J Anaesth 2008; 100(1): 125-30. https://doi.org/10.1093/bja/aem279
  12. Park NS, Bae JI, Park AW, Won JH and Lee HS. Safety and effectiveness of analgesia with remifentanil for percutaneous transhepatic biliary drainage. AJR Am J Roentgenol 2009; 192(5): 1430-3. https://doi.org/10.2214/AJR.08.1755
  13. Milne SE, Kenny GN and Schraag S. Propofol sparing effect of remifentanil using closed-loop anaesthesia. Br J Anaesth 2003; 90(5): 623-9. https://doi.org/10.1093/bja/aeg115
  14. Mertens MJ, Engbers FH, Burm AG and Vuyk J. Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia. Br J Anaesth 2003; 90(2): 132-41. https://doi.org/10.1093/bja/aeg046
  15. Gasparovic S, Rustemovic N, Opacic M, Premuzic M, Korusic A, Bozikov J, et al. Clinical analysis of propofol deep sedation for 1,104 patients undergoing gastrointestinal endoscopic procedures: a three year prospective study. World J Gastroenterol 2006; 12(2): 327-30. https://doi.org/10.3748/wjg.v12.i2.327
  16. Oei-Lim VL, White M, Kalkman CJ, Engbers FH, Makkes PC and Ooms WG. Pharmacokinetics of propofol during conscious sedation using target-controlled infusion in anxious patients undergoing dental treatment. Br J Anaesth 1998; 80(3): 324-31. https://doi.org/10.1093/bja/80.3.324
  17. Klement W and Arndt JO. Pain on injection of propofol: effects of concentration and diluent. Br J Anaesth 1991; 67(3): 281-4. https://doi.org/10.1093/bja/67.3.281
  18. Kwak HJ, Min SK, Kim JS and Kim JY. Prevention of propofol-induced pain in children: combination of alfentanil and lidocaine vs alfentanil or lidocaine alone. Br J Anaesth 2009; 103(3): 410-2. https://doi.org/10.1093/bja/aep163